Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1,9-dideoxyforskolin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 1,9-dideoxyforskolin in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(1,9-dideoxyforskolin)		Trials
(1,9-dideoxyforskolin)		Recent Studies (post-2010) (1,9-dideoxyforskolin)
9,15618755211102

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katz, S; Mok, W; Phaneuf, S; Salari, H; Wong, S1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1,9-dideoxyforskolin

ArticleYear
Forskolin inhibits platelet-activating factor binding to platelet receptors independently of adenylyl cyclase activation.
    European journal of pharmacology, 1993, Mar-15, Volume: 245, Issue:1

    Topics: Adenylyl Cyclases; Animals; Blood Platelets; Cell Membrane; Colforsin; Cyclic AMP; Dinoprostone; Enzyme Activation; GTP-Binding Proteins; In Vitro Techniques; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Rabbits

1993